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A B S T R A C T  
  
The occurrence of seven pharmaceuticals and two metabolites belonging to non-steroidal anti-inﬂammatory drugs and analgesics therapeutic classes was 
studied in seawaters. A total of 101 samples covering fourteen beaches and ﬁve cities were evaluated in order to assess the spatial distribution of 
pharmaceuticals among north Portuguese coast. Seawaters were selected in order to embrace different bathing water quality (excellent, good and sufﬁcient). 
Acetaminophen, ketoprofen and the metabolite hydroxyibuprofen were detected in all the 
seawater samples at maximum concentrations of 584, 89.7 and 287 ng L−1, respectively. Carboxyibuprofen had 
the highest seawater concentration (1227 ng L−1). The temporal distribution of the selected pharmaceuticals during the bathing season showed that, in general, 
higher concentrations were detected in August and Septem- ber. The environmental risk posed by the pharmaceuticals detected in seawaters towards different 
trophic levels (ﬁsh, daphnids and algae) was also assessed. Only diclofenac showed hazard quotients above one for ﬁsh, representing a potential risk for 
aquatic organisms. These results were observed in seawaters classiﬁed as excellent bathing water. Additional data is needed in order to support the identiﬁcation 
and prioritization of risks posed by pharmaceuticals in marine environment. 
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1. Introduction 
 
In the last few years, a special attention has been given to the assess- ment of 
the presence of emerging pollutants in natural waters and their effects on 
ecosystems. As the analytical capacity has improved in order to allow the 
quantiﬁcation of very low concentrations (e.g. in the ng L−1 range) with the high 
degree of certainty given by the use of tandem mass spectrometry, scientists 
have been able to quantify these xenobi- otics in the aquatic systems (surface 
waters, ground waters, treated and untreated wastewaters and even tap 
waters) (Loos et al., 2010, 
2013a). 
Pharmaceuticals play an important role in assuring populations' health. 
However their use is not exempt from negative effects whose importance just 
more recently has been recognized. Indeed, every day tons of these 
compounds are loaded in the sewage systems and reach wastewater 
treatment plants (WWTPs). These have been mainly de- signed to remove 
suspended solids and organic loadings and their effect on the removal of 
micropollutants may be, in some cases, negligible. In fact, the removal 
efﬁciency of pharmaceuticals in WWTPs have been studied and a very wide 
range of values is observed, from compounds which pass these plants almost 
intact and others presenting a removal efﬁciency close to 100% (Kunkel and 
Radke, 2012). Their incomplete re- moval makes that there is a continuous 
discharge of pharmaceuticals into the environment, which may result in a 
chronic exposure of aquatic organisms to these compounds and/or their 
bioactive metabolites and transformation products. These products have 
shown, in some cases, quite similar toxicological consequences in aquatic 
environment. 
Although the present knowledge in the occurrence and behaviour of 
pharmaceuticals in surface waters is well documented (e.g. Gros et al., 
2006, 2012; Paíga et al., 2013; Rabiet et al., 2006), such knowledge in seawaters 
is still very limited and recent. 
The presence of pharmaceuticals in seawaters has been evaluated in different 
geographical areas, namely in the North Sea (Weigel et al., 2002), 
Mediterranean Sea (Gros et al., 2012; Rodriguez-Navas et al., 2013; Togola 
and Budzinski, 2008), Adriatic Sea (Loos et al., 2013b) and in the Paciﬁc (Vidal-
Dorsch et al., 2012) and Indian Oceans (Fang et al., 2012; Wu et al., 2010). 
Several therapeutic groups were studied, including, for example, non-steroidal 
anti-inﬂammatory drugs (NSAIDs) (Gros et al., 2012; Wille et al., 2010), 
analgesics (Gros et al., 2012; Nödler et al., 2010), antibiotics (Nebot et al., 2007; 
Wille et al., 2010), β- blockers (Gros et al., 2012; Wille et al., 2010), lipid 
regulators (Fang et al., 2012; Gros et al., 2012) and psychiatric drugs (Gros et 
al., 2012; Wille et al., 2010). Diclofenac (Rodriguez-Navas et al., 2013), ibuprofen 
(Loos et al., 2013b), naproxen (Vidal-Dorsch et al., 2012), ketoprofen (Gros et 
al., 2012), salicylic acid (Wille et al., 2010), acetaminophen (Gros et al., 2012) 
and codeine (Gros et al., 2012) are among the most de- tected NSAIDs/analgesics in 
seawaters of the North, Mediterranean and Adriatic Seas and even in the Paciﬁc 
and Indian Oceans at levels up to 
few hundred ng L−1. Some examples of levels of NSAIDs/analgesics de- 
tected in seawaters are present in Table 1. 
Recently, European Union established regulatory guidance to as- sess the 
presence of pharmaceuticals in the aquatic environment (Directive 
2013/39/EU amending Directives 2000/60/EC and 2008/ 105/EC) (European 
Comission, 2013) as regards priority substances in the ﬁeld of water policy. A 
watch list of pharmaceuticals including the sex hormones 17alpha-
ethinylestradiol and 17beta-estradiol, and the NSAID diclofenac was created 
and is being updated with data gath- ered among the European Union countries. 
Regarding marine waters, 
 
 
 
Table 1 
Examples of concentrations of NSAIDS/analgesics found in seawaters. 
 
Pharmaceutical Seawater Country Concentration (ng/L− 1) Reference 
Acetaminophen Mediterranean Sea Spain 23 Gros et  al. (2012) 
  France ~ 200,000 Togola and Budzinski 
(2008) Diclofenac North Sea UK b 0.12 Nebot et  al. (2007) 
 Mediterranean Sea Spain 4 Gros et  al. (2012) 
  Spain n.d.–b LOQ Rodriguez-Navas et al. 
(2013)   France ~ 1500 Togola and Budzinski 
(2008)  Indian Ocean Singapore 4–38 Wu et al. (2010) 
  Taiwan b 2.5–53.6 Fang et al. (2012) 
Ibuprofen North Sea UK b 0.52 Nebot et  al. (2007) 
 Mediterranean Sea Spain 16 Gros et  al. (2012) 
  France ~ 1500 Togola and Budzinski 
(2008)  Adriatic sea Italy b 0.049–1.146 Loos et  al. (2013b) 
 Indian Ocean Singapore 41–121 Wu et al. (2010) 
  Taiwan b 2.5–57.1 Fang et al. (2012) 
Ketoprofen Mediterranean Sea Spain b 8.0 Gros et  al. (2012) 
  France ~ 6000 Togola and Budzinski 
(2008)  Indian Ocean Taiwan b 1.7–6.59 Fang et al. (2012) 
Naproxen Mediterranean Sea Spain 6 Gros et  al. (2012) 
  
Paciﬁc Ocean 
Franc
e USA 
~ 
2000 
n.d.–
26 
Togola and Budzinski 
(2008) Vidal-Dorsch et  
al. (2012) 
 Indian Ocean Singapore 13–30 Wu et al. (2010) 
Acetylsalicylic acid Mediterranean Sea France ~ 8000 Togola and Budzinski 
(2008) Salicylic acid North Sea Belgium n.d.–855 Wille et al. (2010) 
 Mediterranean Sea Spain 2 Gros et  al. (2012) 
Mefenamic acid North Sea UK b 0.04 Nebot et  al. (2007) 
Indomethacine Mediterranean Sea Spain 3 Gros et  al. (2012) 
Phenazone Mediterranean Sea Spain 2 Gros et  al. (2012) 
Propyphenazone Mediterranean Sea Spain b 0.6 Gros et  al. (2012) 
Codeine Mediterranean Sea Spain 2 Gros et  al. (2012) 
  
monitoring programmes for continuous evaluation of their environ- mental 
status should be established according to the Marine Strategy Framework 
Directive (European Comission, 2008), including the evalu- ation of the impact of 
hazardous substances as pharmaceuticals. 
Coastal areas represent a major asset due to the economic activities that may 
take place, including tourism, commercial ports and harbours and certain types of 
traditional ﬁshing. Due to their location, coastal sea- waters may be more prone to 
present higher pharmaceutical concentra- tions than other seawater samples 
(Loos et al., 2013b; Wille et al., 2010). In Portugal, coastal areas are the most 
densely populated regions where the largest cities and the most important 
industries are situated. To the best of our knowledge, the only data available 
about the occur- rence of pharmaceuticals in Portuguese seawaters is 
reported in our 
previous work (Paíga et al., in press). 
The purpose of this work was to evaluate the occurrence of seven 
pharmaceuticals and two metabolites belonging to NSAIDs/analgesics group in 
seawaters, in a total of 101 samples, collected in the summer season of 2013 
from 14 beaches. Compounds were selected based on their high 
consumption among Portuguese population (INFARMED, 2012) and to 
previous studies of our group that showed their presence in Portuguese 
environment, namely wastewaters (Santos et al., 2013a) and surface waters 
(Paíga et al., 2013), at levels that could pose a risk for aquatic organisms. 
Differences observed between municipalities, tem- poral variations as well as 
environmental risk will be discussed. 
 
2. Materials and methods 
 
2.1. Reagents, solvents and materials 
 
All pharmaceutical standards were of high purity grade (≥ 98%). 
Ibuprofen,  1-hydroxyibuprofen,  carboxyibuprofen, acetaminophen, 
acetylsalicylic acid, naproxen, nimesulide, ketoprofen and diclofenac were 
purchased from Sigma-Aldrich (Spain). Diclofenac was pur- chased in the 
form of sodium salt. The isotopically labelled com- pound ibuprofen-d3 
used as internal standard was also purchased from Sigma-Aldrich. 
Both individual stock standard and isotopically labelled internal standard 
solutions (at a concentration of 1000 mg L−1) were prepared on a weight basis 
in acetonitrile, except for naproxen and diclofenac, which were prepared in 
acetonitrile–methanol (50:50, v/v). All stock standard solutions were 
prepared every six months and were stored at − 20 °C. Working standard 
solutions containing all pharmaceuticals were prepared in acetonitrile-ultra-
pure water (30:70, v/v) by mixing 
appropriate amounts of the stock solutions. These solutions were pre- pared 
before each analytical run. 
Acetonitrile and methanol for LC–MS were supplied by J.T. Baker 
(Deventer, Netherlands), and hydrochloric acid 37% was obtained from Carlo 
Erba (Rodano, Italy). 
Ultra-pure water (resistivity of 18.2 MΩ·cm) was produced using a 
Simplicity 185 system (Millipore, Molsheim, France). All chromato- graphic 
solvents were ﬁltered through a 0.22 μm nylon membrane ﬁlter (Supelco, 
Bellefonte, PA, USA) using a vacuum pump (Dinko D-95, Barcelona, Spain) 
and degassed for 15 min in an ultrasonic bath (Sonorex Digital 10P, Bandelin 
DK 255P, Germany). 
Solid phase extraction (SPE) was performed using Strata-X car- tridges 
(200 mg, 3 mL) from Phenomenex (USA). 
 
2.2. Sampling sites and sample collection 
 
Seawater samples were collected in the Atlantic Ocean along the North 
Portuguese coast, covering fourteen beaches from ﬁve cities and surrounding 
area (Vila do Conde, Matosinhos, Porto, Vila Nova de Gaia and Espinho) (Fig. 1 
and Table S1, Supporting material). The area of study is densely populated and 
embraces coastal waters that receive water from different river basins, which 
have a strong impact of anthro- pogenic activities, as WWTP discharges, untreated 
efﬂuents, and agricul- tural runoffs. Therefore, different organic pollutants have 
been detected in Ave (Rocha et al., 2013), Leça (Rocha et al., 2012) and Douro 
rivers (Ribeiro et al., 2009), including pharmaceuticals (Gonçalves et al., 
2013; Madureira et al., 2010; Paíga et al., 2013). 
In Vila do Conde two beaches were sampled (Frente Urbana and 
Mindelo), being the former located on the mouth of Ave river. This area is 
impacted by the discharges of a WWTP, which serves 258,000 pop- ulation 
equivalents (p.e.) and has primary, secondary and tertiary treat- ments. In 
Matosinhos four beaches (Angeiras Norte, Azul (Conchinha), Leça da Palmeira 
and Matosinhos) were studied. Leça river ﬂows into the Atlantic Ocean in the 
area of Leça da Palmeira and Matosinhos beaches. In this area the second 
biggest artiﬁcial Portuguese harbour (Leixões harbour) and a reﬁnery of 
petroleum derivates are also located. Additionally there are four WWTPs with 
different capacities (from 17,000 to 80,000 p.e.) that discharge their 
efﬂuents into rivers and streams that ﬂow into the Atlantic Ocean, and even 
directly into seawater, in Matosinhos area. All these WWTPs have primary and 
secondary treat- ments by activated sludge. Porto is the second most 
populous city of Portugal and two beaches were chosen in its coastal area 
(Castelo do Queijo and Foz). Foz beach is located in the mouth of Douro 
river, a river basin which receives discharges from several WWTPs either by di- 
rect discharge (2 WWTPs) or through its tributaries (4 WWTPs). Those WWTPs 
vary in their capacity (from 45,000 to 200,000 p.e.) as well as in the treatments 
applied (primary, secondary and, in some cases, even 
 
 
 
Fig. 1. Seawater sampling points and wastewater treatment plants (WWTPs) in the study area. 1 to 14 — seawater samples; 15 to 27 — 
WWTPs. 
  
tertiary treatments by sand ﬁltration and UV disinfection). Three beaches of Vila 
Nova de Gaia area, namely Lavadores, Miramar and São Félix da Marinha were 
also sampled. The ﬁrst one is located near the mouth of the Douro river while 
the others receive small streams. It is in this area that is located a large WWTP that 
serves 300,000 p.e. and has primary, secondary and tertiary treatment that 
discharges its efﬂuents directly into the Atlantic Ocean at 30 m of depth. Finally, 
three beaches of Espinho area were also studied (Seca, Frente azul and Espinho-
Baía). This coastal area also receives small streams of surrounding environment 
and there is a WWTP, which discharges its efﬂuents directly into the Atlantic 
Ocean in the vicinity of the studied seawaters. It serves 100,000 p.e. and has 
primary and secondary treatments. 
Sampling locations were chosen taking into account the bathing water 
quality, therefore beaches with bathing water quality classiﬁed as excellent, 
good and sufﬁcient, according to European regulation (European Comission, 
2006), were taken into consideration, namely seven beaches of excellent, four 
of good, and three of sufﬁcient. Howev- er it should be highlighted that bathing 
water quality classiﬁcation only takes into account microbiological parameters 
(European Comission, 2006). Detailed information on sampling sites and their 
geographical lo- cation (GPS) are given in Tables S1 and S2 (Supporting material). 
Sam- pling campaigns took place during the bathing season from June to 
September 2013. Sampling frequency was determined taking into ac- count 
the bathing water quality, thus for excellent bathing waters, sam- ples were only 
collected once a month; for good every two weeks; and for sufﬁcient bathing 
waters every week. A total of 101 samples were collected for further analysis. 
1.5 L of seawater was collected in bottles previously rinsed with ultra-pure 
water as grab samples and at a depth of at least 1 m. Samples were kept at 4 
°C during the transport to the laboratory. Upon reception, samples were 
vacuum ﬁltered through 1.2 μm glass microﬁber ﬁlters (GF/C, Whatman, UK), 
followed 
by 0.22 μm nylon membrane ﬁlters and stored at − 20 °C, until extrac- 
tion. The detected concentrations of pharmaceuticals correspond to their 
dissolved fraction, since suspended solids were removed during sample 
preparation. 
Data relative to seawater temperature and pH, environmental tem- 
perature, and microbiological determinations of Escherichia coli and 
Enterococcus were given by the Portuguese Environment Agency (APA, 2013). 
 
 
2.3. Analytical method 
 
Sample preparation and analysis were made according to the proce- dure 
described in (Paíga et al., in press). Brieﬂy, after ﬁltration, sample's pH was adjusted 
to 2.0 with concentrated hydrochloric acid and 500 mL of seawater was loaded 
onto Strata-X cartridges (200 mg, 3 mL) previ- ously conditioned with 5 mL of 
methanol followed by 5 mL of ultra- pure water and 5 mL of ultra-pure water 
pH 2. Afterwards the cartridge was rinsed with 5 mL of ultra-pure water and then 
dried under vacuum for 1 h to remove the excess water. Elution was 
performed with  2 
× 5 mL of methanol. The extract was evaporated until dryness under a gentle 
stream of nitrogen and reconstituted with 1 mL of acetonitrile- 
ultra-pure water (30:70, v/v). Finally, 10 μL of an ibuprofen-d3 standard solution 
was added to obtain a ﬁnal concentration of 50 mg L−1 in the ex- tract as internal 
standard. 
Instrumental analysis was performed on a Shimadzu Nexera UHPLC system 
(Shimadzu Corporation, Kyoto, Japan), equipped with two solvent delivery 
modules, a column oven, an autosampler, and coupled with a Shimadzu LCMS-
8030 triple quadrupole mass spectrometer (Shimadzu Corporation, Kyoto, 
Japan). Lab Solutions software (Shimadzu Corporation, Kyoto, Japan) was used for 
control and data processing. Chromatographic separation was achieved in a 
Kinetex C18 column (2.6 
× 150 mm i.d., 1.7 μm particle size) from Phenomenex (USA), using ultra-pure 
water as solvent A and acetonitrile as solvent B at a ﬂow rate of 0.22 mL min−1. 
The injection volume was 5 μL and column oven was 
set at 30 °C. The autosampler was operated at 4 °C. Pharmaceuticals were 
analyzed in the negative ESI mode. 
Quantiﬁcation of analytes was performed in multiple reaction mon- itoring 
mode (MRM) and two transitions between the precursor ion and the most 
abundant fragment ions were monitored for each com- pound, as described 
in detail elsewhere (Paíga et al., in press). The most intense was used as 
quantiﬁer and the second one as qualiﬁer. In the case of acetaminophen, 
hydroxyibuprofen, ketoprofen, ibuprofen and ibuprofen-d3 only one transition 
could be recorded due to their poor fragmentation. A dwell time of 25 ms was 
used for all compounds. Detailed information of the optimized mass 
spectrometer parameters is shown in Table S3 (Supporting material). 
 
 
2.4. Statistical analysis 
 
Prior to multivariate data analysis, univariate descriptive statistics analysis 
was made (minimum, maximum, mean, median, standard de- viation and 
frequency of detection) for the different measured variables (pharmaceutical's 
concentration, seawater temperature, seawater pH, environmental 
temperature, and microbiological determinations  of 
E. coli and Enterococcus). Pairwise correlation between two variables was 
also investigated in order to evaluate if there are correlation be- tween the 
different studied variables. 
After determining the frequency of detection for the studied phar- 
maceuticals, only the compounds that were detected in more than 10% of 
seawater samples were considered for further multivariate data analysis 
(Navarro et al., 2010). Therefore, microbiological parameters (E. coli and 
Enterococcus) and the concentration of six pharmaceuticals and one 
metabolite were considered. 
For multivariate data analysis, special attention has to be taken into account 
for values below the detection limit and for the presence of missing values. 
For the former, values were assumed to be equal to half of the limit of 
detection (Navarro et al., 2010). Limits of detection are present in Table 2. 
While the missing values were estimated using multiple imputation by chained 
equations (Azur et al., 2011). 
Principal Component Analysis (PCA) was set with the variables acet- 
aminophen, diclofenac, hydroxyibuprofen, ibuprofen, naproxen, and 
ketoprofen (using the concentrations found in seawater), E. coli and 
Enterococcus (expressed in colony forming units (CFU) per 100 mL). 
Components with eigenvalues higher than 1 were retained for further analysis. 
Statistical analysis was performed using SPSS software, version 20.0 (SPSS Inc., 
Chicago, Illinois). A two-tailed p value b 0.05 was considered to indicate statistical 
signiﬁcance. 
 
 
2.5. Environmental risk assessment 
 
Environmental risk assessment of studied pharmaceuticals was evaluated 
regarding their hazard quotient (HQ), using three different trophic levels 
representative of the aquatic ecosystem (algae, daphnids and ﬁsh). HQs were 
calculated according to EU guidelines (European Comission, 2003) as the 
quotient between the measured environmental concentration (MEC) and 
predicted no-effect concentration (PNEC), where the maximum individual 
concentration of each pharmaceutical found in seawater samples from the 
different studied beaches was used as MEC. PNEC values were estimated using 
the lowest acute eco- toxicological data reported in literature (EC50 or LC50) 
for short term standard toxicity studies using species from three different 
trophic levels (ﬁsh, Daphnia and algae) and applying an assessment factor (usu- 
ally 1000) (European Comission, 2003), in order to set up a worst case scenario. 
Detailed ecotoxicological data used for each pharmaceutical is summarized in 
the Supporting material (Table S4). If HQ is equal or above 1 there is a potential 
environmental risk situation, whereas when lower than 1, no risk is expected 
(Straub, 2002). 
  
Table 2 
Summary data for the different parameters evaluated in Portuguese seawaters. 
 
 MDL Min  Max Median  Mean  SD FD  
Compounds (ng 
L−1) 
(ng L− 
1) 
 
(ng L−1) (ng 
L−1) 
 
(ng L− 
1) 
 (ng 
L−1) 
(%)  
Acetaminophen 0.30 51.2  584 62.8  95.2  91.9 100  
Acetylsalicylic acid 0.10 n.d.  5.34 5.03  4.99  0.33 4  
Carboxyibuprofen 8.18 n.d.  1227 270  400  410 7  
Diclofenac 0.02 n.d.  241 13.7  30.6  58.8 27  
Hydroxyibuprofen 3.90 22.4  287 35.0  38.9  35.4 100  
Ibuprofen 0.08 n.d.  222 27.0  25.2  28.3 97  
Naproxen 0.02 n.d.  178 28.0  32.4  30.5 54  
Nimesulide 0.06 n.d.  7.33 4.49  1.91  2.31 11  
Ketoprofen 0.30 10.3  89.7 13.7  14.2  8.97 100  
Environmental  parameters 
 
Min 
 
Max 
 
Median 
 
Mea
n 
 
SD 
 
Seawater pH  7.65  8.36  7.97  7.9
8 
 0.16  
Environmental 
temperature (°C) 
 18.5  26.0  21.5  21.6  2.35  
S awater temperature (°C)  16.1  19.9  17.4  17.7  1.14  
Microbiological parameters LOQ Min Max Median Mean SD FD (%) 
Escherichia coli (CFU/100 mL) 15 b LOQ 5352 15.0 114 544 100 
Enterococcus  (CFU/100 mL) 15 b LOQ 1202 7.50 26.7 123 100 
MDL — method detection limit; Min — minimum concentration; Max — maximum concentration; SD — standard deviation; FD — frequency of detection; LOQ 
— limit of quantiﬁcation; n.d. — not detected. 
 
3. Results and discussion 
 
3.1. Occurrence of pharmaceuticals in Portuguese seawaters: 
geographical and temporal variation 
 
Table 2 summarizes the results obtained for the occurrence of the se- lected 
pharmaceuticals in seawater. Three out of nine pharmaceuticals were detected 
in all the samples, namely acetaminophen, ketoprofen and the metabolite 
hydroxyibuprofen. Maximum concentrations of pharmaceuticals ranged 
between 5.34 ng L− 1 and 1227 ng L− 1, for acetylsalicylic acid and 
carboxyibuprofen, respectively. However, only in the coastal waters of 
Matosinhos and Espinho it was possible to detect all the studied pharmaceuticals at 
least in one sample. Among the differ- ent studied cities, concentration ranges 
were between 1.76 ng L− 1 (nimesulide) and 76.9 ng L− 1 
(acetaminophen) for Vila do Conde seawaters, between 2.49 ng L− 1 
(nimesulide) and 600 ng L− 1 (carboxyibuprofen) for Matosinhos 
seawaters, between 5.24 ng L− 1 (nimesulide) and 1227 ng L−1 
(carboxyibuprofen) for Porto seawaters, between 0.69 ng L−1 (nimesulide) 
and 241 ng L−1 (diclofenac) for Vila Nova de Gaia seawaters, and between 5.12 
ng L−1 (acetylsalicylic acid) and 236 ng L−1 (carboxyibuprofen) for Espinho 
seawaters (Fig. 2). Re- garding the distribution of acetaminophen 
concentrations, according to the results of the post-hoc tests, Porto is signiﬁcantly 
different from Vila Nova de Gaia (p = 0.022) and Espinho (p = 0.014) (Fig. 2) 
when a p ≤ 0.05 was considered. 
In general, the highest concentrations of pharmaceuticals   were 
found in seawaters from Porto coastal area. Compounds like acetamin- ophen, 
naproxen, ibuprofen and its two metabolites (carboxyibuprofen and 
hydroxyibuprofen) recorded its highest concentrations in seawater samples 
from Castelo do Queijo beach, reaching levels of few micro- grams per litre 
(Tables S5–S9, Supporting material). These results may be due to the negative 
pressures of different anthropogenic activities in this beach, given that 
WWTPs located in the surrounding area discharge their efﬂuents in this 
point and this beach is also impacted by Leixões harbour activities. The 
discharge of untreated efﬂuents may also occur. Castelo do Queijo beach is 
also located in the vicinity of Leça and Douro river mouths, where the presence 
of NSAIDs and an- algesics had been reported (Gonçalves et al., 2013; Paíga et 
al., 2013; 
Santos et al., 2013b). Indeed, in a previous work ibuprofen was detected in Douro 
and Leça river mouths at levels up  to  232  ng  L− 1 and 256 ng L− 1, 
respectively (Paíga et al., 2013). On the other hand, the highest 
concentrations of nimesulide and ketoprofen were detected in 
Espinho coastal area (Fig. 2), being the former found in Seca beach while the 
latter occurred in Espinho-Baía beach (Table S9, Supporting material). It is 
worth noting that the highest level of ketoprofen (89.7 ng L−1) was 
detected in seawater classiﬁed as excellent for bath- ing water quality. The 
occurrence of pharmaceuticals in Espinho coastal waters can be explained by the 
presence of a WWTP in the area of study, which serves 100,000 p.e. and 
discharges its efﬂuents directly to the Atlantic Ocean. For diclofenac and 
acetylsalicylic acid, the highest con- centrations were found in Vila Nova de Gaia 
coastal area, in Lavadores beach and São Félix da Marinha beach, respectively (Fig. 
2 and Table S8, Supporting material). As it happens for ketoprofen, the highest 
concentra- 
tion of diclofenac was also detected in a beach classiﬁed as excellent for bathing 
water quality. However, Lavadores beach is located in the vicinity of Douro river 
mouth and, therefore, being impacted by the pollutants present herein, namely 
pharmaceuticals. Ralo stream is also a tributary for this beach that might be 
pointed out as a possible source of contami- nation. Relative to São Félix da Marinha 
beach, in its surrounding area a WWTP that serves 300,000 p.e. is located and 
discharges its efﬂuents di- rectly into the Atlantic Ocean, which may contribute to 
the entrance of pharmaceuticals into seawaters. Another possible source of 
contamina- tion for this beach is its tributary Prego stream. 
Data on the presence of pharmaceuticals in seawaters is still sparse and there 
are only a few studies focusing in this topic. Lower concentra- tions of NSAIDs 
were reported in Mediterranean Sea (Spain) (Gros et al., 2012; Rodriguez-Navas et 
al., 2013), in Singapore coastal waters (Bayen et al., 2013) and in the Paciﬁc Ocean 
(California, USA) (Bay et al., 2012; Vidal-Dorsch et al., 2012), being usually the 
concentrations detected one order of magnitude lower than those reported in 
this study. Ibupro- fen was also detected in Adriatic Sea at levels up to 1.146 ng 
L−1 (Loos et al., 2013b). On the other hand, Wu et al. (2010) reported similar 
ﬁnd- ings for naproxen and diclofenac in Marine Bay (Singapore) (Wu et al., 
2010). In Taiwan coastal waters, the concentrations of diclofenac and 
ibuprofen were also in the same order of magnitude of those reported herein, 
though ketoprofen was detected at lower levels, not exceeding 7 ng L− 1 (Fang 
et al., 2012). Nevertheless, Nödler et al. (2010) were not able to detect 
diclofenac, ibuprofen, naproxen and acetaminophen in the Baltic Sea (German 
coastal area) (Nödler et al., 2010). 
Albeit the high consumption of acetylsalicylic acid among Portu- guese 
population (INFARMED, 2012), it was only detected in 4% of the seawater 
samples, at a maximum concentration of 5.34 ng L− 1 (Table 2). These low 
levels might be justiﬁed by its ready biodegrada- tion in the aquatic 
environment, forming salicylic acid, a more active 
  
 
 
Fig. 2. Box plots indicating the distribution of some pharmaceuticals concentration, expressed in ng L−1, among the studied cities. Please note that the scale for 
the y-axis (concentration in ng L−1) changes between boxes. ○ — outlier values;★ — extreme outlier values. Comparisons between cities were assessed 
with the Kruskal–Wallis test followed by post hoc tests. ns — 
not signiﬁcant. 
 
metabolite (Cleuvers, 2004; Rabiet et al., 2006) together with its high removal 
efﬁciency in WWTPs that may range from 80 to 98% (Ziylan and Ince, 2011). 
No data on the occurrence of acetylsalicylic acid in sea- waters is available in 
literature, though the presence of its main metab- olite salicylic acid had been 
reported in the Belgian coastal area (North Sea) (Wille et al., 2010) and in the 
Mediterranean Sea (Spain) (Gros et al., 2012), at levels up to 660 ng L−1. 
On the other hand, the ibuprofen metabolite carboxyibuprofen showed 
the highest concentration detected in Portuguese seawaters (up to 1227 ng 
L−1) (Table 2). However, in spite of its high concentra- tion, carboxyibuprofen 
was only detected in 7% of the seawater samples, contrarily to what happens 
with ibuprofen and its metabolite hydroxyibuprofen that have a frequency of 
detection of 97 and 100%, re- spectively, with their concentrations reaching 222 
ng L−1 for ibuprofen and 287 ng L−1 for hydroxyibuprofen. Although when 
ibuprofen and its two metabolites were detected in the same sample, 
carboxyibuprofen always showed the highest concentration, as was expected 
since it is the human metabolite of ibuprofen with highest percentage of 
excre- tion (43%) (Farré et al., 2008). The same pattern was observed by 
Weigel et al. (2004) in seawater samples from the Norwegian coast (Tromsø) 
(Weigel et al., 2004). Nevertheless, hydroxyibuprofen  showed 
to be more stable than ibuprofen and carboxyibuprofen, which is in 
agreement with data from literature that indicates hydroxyibuprofen as the less 
biodegradable compound (Ferrando-Climent et al., 2012; Winkler et al., 2001). Due to 
its high biodegradability in the environment, the pres- ence of carboxyibuprofen in 
seawaters might be attributed to discharges of WWTP efﬂuents or even of 
untreated efﬂuents. Carboxyibuprofen was detected in seawaters from four 
beaches, being two of them classiﬁed as excellent for bathing water quality, 
namely Foz beach (Porto) and Espinho-Baía beach (Espinho), and the other two 
have classiﬁcation of sufﬁcient (Azul Conchinha beach (Matosinhos) and 
Castelo do Queijo beach (Porto)) (Tables S5–S9, Supporting material). 
The temporal variation of pharmaceuticals' concentration was followed 
along the bathing season, from June to September 2013 (Fig. 3). Taking into 
account the compounds with high frequency of de- tection, it was observed that 
the highest concentrations were registered in August and September, with the 
exception of ketoprofen that showed a constant proﬁle along the bathing season, 
registering a small variation in its concentration. The behaviour of ketoprofen 
might be justiﬁed by its difﬁcult removal during wastewater treatment, being 
consistently found in surface waters (Shanmugam et al., 2014). Ketoprofen 
can also occur as ion at neutral or basic pH, and therefore is not readily 
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Fig. 3. Temporal distribution of most relevant pharmaceuticals along the bathing season in the different cities. 
 
 
adsorbed on particulate material, remaining in the aqueous phase (Araujo et 
al., 2014). On the other hand, the higher levels of pharmaceu- ticals observed in 
August and early September can be explained by an increase in population in 
the study area during these months, due to a higher level of tourists at that 
time, either by summer holidays or by 
an increment in the trafﬁc of cruise boats in Leixões harbour (INE, 2014). 
Additionally, in August and September raining events are also less abundant, 
making that rivers and streams have a small capacity, being more negatively 
impacted by human activities as the discharges of WWTPs efﬂuents, due to the 
dilution of pharmaceuticals in surface 
 
 
Table 3 
Pairwise correlation coefﬁcients between the variables. 
 
 ACET DICL HYDR IBUP NAPR NIME KETOP pH EMT SWT EC 
ACET 1           
DICL 0.118 1          
HYDR 0.221 0.423 1         
IBUP 0.111 0.024 0.682 1        
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NAPR 0.486 0.188 0.292 0.020 1       
NIME 0.379 − 0.454 − 0.216 0.011 − 0.214 1      
KETOP − 0.026 − 0.117 − 0.015 − 0.005 − 0.045 0.212 1     
pH − 0.152 − 0.161 0.109 0.082 0.144 0.140 − 0.064 1    
EMT 0.295 0.378 0.144 − 0.029 0.103 − 0.050 − 0.061 − 0.474 1   
SWT − 0.183 − 0.230 − 0.033 0.154 − 0.244 0.145 − 0.122 0.376 − 0.128 1  
EC 0.037 0.526 0.036 − 0.015 − 0.054 − 0.226 0.407 − 0.029 − 0.159 − 0.151 1 
ENT 0.006 − 0.129 − 0.017 − 0.049 − 0.064 0.426 0.392 − 0.036 − 0.135 − 0.134 0.978 
Signiﬁcant pairwise correlations are marked in bold (signiﬁcance 5%). 
ACET — acetaminophen; DICL — Diclofenac; HYDR — hydroxyibuprofen; IBUP — ibuprofen; NAPR — naproxen; NIME — nimesulide; KETOP — ketoprofen; pH — 
seawater pH; EMT — environ- mental medium temperature; SWT — seawater temperature; EC — Escherichia coli; ENT — Enterococcus. 
  
 
 
 
 
Fig. 4. Component loadings plot in rotated space. 
 
 
waters being less pronounced, which can be reﬂected in a higher impact of 
anthropogenic activities into seawaters. 
 
3.2. Statistical analysis 
 
In Table 3, pairwise correlations between the studied variables are given. As 
expected, there was a strong correlation between microbio- logical 
parameters (E. coli and Enterococcus), since both parameters are indicators 
of faecal contamination and of a negative impact of human activities in 
seawaters. Relatively to physicochemical variables, there was a negative 
correlation between environmental temperature and seawater pH, while this 
latter parameter was positively correlated with seawater temperature. 
Concerning pharmaceuticals, acetamino- phen, diclofenac, ibuprofen, 
hydroxyibuprofen and naproxen showed correlations among each other. 
These suggested a possible common source of entrance into seawaters for the 
studied pharmaceuticals. Ad- ditionally, ibuprofen and its metabolite 
hydroxyibuprofen had a moder- ate correlation, what was expected due to the 
stability of this metabolite and its pattern of occurrence together with the 
parent compound (see Section 3.1.). Pharmaceuticals like diclofenac and 
ketoprofen also had a positive correlation with the microbiological parameters 
(E. coli and Enterococcus),  which may suggest a common  source of  
entrance   of 
pharmaceuticals and these biomarkers of faecal contamination into sea- waters. 
The most probable source of contamination should be WWTP efﬂuents and 
untreated efﬂuents that are directly discharged into the environment. 
To better understand the multivariate correlations among the differ- ent 
variables, seawater sampling locations and seawater bathing water quality, a 
Principal Component Analysis (PCA) was made. PCA was per- formed combining 
the data obtained for pharmaceuticals and the mi- crobiological parameters. 
The ﬁrst three principal components (PCs) explained 68% of the variance and 
their loading plots are represented in Fig. 4. It can be seen that the ﬁrst PC had 
positive loadings for E. coli, Enterococcus and ketoprofen, while for the second 
PC contributed the compounds diclofenac, ibuprofen and hydroxyibuprofen. 
Finally, the pharmaceuticals acetaminophen and naproxen have high positive 
load- ings in the third PC. Both microbiological parameters have high loadings in the 
ﬁrst PC, allowing the identiﬁcation of a source contamination by WWTP 
efﬂuents or untreated efﬂuents, which are positively correlated with the 
concentration of ketoprofen. These results are in agreement with the 
correlation coefﬁcients found for these variables (Table 3). 
In Fig. 5, the PC1 vs. PC2 vs. PC3 score plots of data are shown. In order to 
better analyze the results obtained, samples were arranged ac- cording to their 
city of origin (Fig. 5a) and their classiﬁcation of bathing water quality (Fig. 5b). 
From Fig. 5a it can be seen that there is not a very clear spatial distribution of the 
samples by their origin. However, sam- ples from cities of Porto and 
Matosinhos can be gathered in a cluster, that presents high positive score 
values for PC2 combined with positive score values in PC3 and PC1, indicating 
that these sampling locations had the highest concentration of 
pharmaceuticals. Correlating the dif- ferent studied variables with the 
classiﬁcation of bathing water quality (Fig. 5b), two groups were distinguished. 
The ﬁrst cluster includes sam- ples from seawaters classiﬁed as sufﬁcient, 
showing high positive score values for PC2 and PC3. This may indicate that these 
samples have a more pronounced impact of human activities, since they have 
higher concentration of pharmaceuticals. The other cluster gathers seawaters 
classiﬁed as excellent or good, showing also positive score values for PC2 and 
PC3, but not as high as in the ﬁrst cluster. 
 
3.3. Environmental risk assessment 
 
Besides the quantiﬁcation of emergent pollutants in the environ- ment, it 
is also important to evaluate potential ecological risks that they may pose to 
non-target organisms at environmental levels. In this way, hazard quotients 
(HQ) can be a useful tool, establishing the quotient between Predicted 
Environmental Concentration (PEC) and Predicted No-Effect Concentration 
(PNEC) (Ginebreda et al.,  2010; 
 
 
 
Fig. 5. Score plots from PCA. a) For the different cities; b) for bathing water quality. 
  
Verlicchi et al., 2012). The replacement of PEC values by Measured Envi- ronmental 
Concentration (MEC) allows a more realistic scenario to as- sess environmental 
risk posed by pollutants as pharmaceuticals. 
In this work, environmental risk assessment was evaluated for three different 
trophic levels (algae, daphnids and ﬁsh). HQs were calculated for the seawaters 
collected in the different beaches using an approach of “worst case scenario”, 
that is the highest level detected for each phar- maceutical was used as MEC. 
Due to the sparse data for ecotoxicological 
effects in marine organisms available in literature, environmental risk 
assessment was evaluated considering ecotoxicological data for fresh- water 
organisms. Fig. 6 summarizes the HQs obtained. As can be seen, ﬁsh showed 
higher HQs and was the only specie that had HQs higher than one, while 
daphnids and algae had similar sensitivity to the detect- ed pharmaceuticals and 
never exceeded the threshold value of one. Diclofenac was the 
pharmaceutical that registered the highest HQs for ﬁsh and in two sampling 
points (Azul Conchinha (Matosinhos)  and 
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Fig. 6. Hazard quotients of seawaters from different locations for three trophic levels. a) ﬁsh; b) daphnid; c) algae. Bold line marks hazard quotient 
equal to one. 
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Lavadores (Vila Nova de Gaia)) it was higher than one (Fig. 6a). Ibupro- fen also 
showed high HQs for ﬁsh, although the threshold limit was never exceeded. 
For daphnids, the highest HQs were obtained for acet- aminophen (Fig. 6b), while 
algae showed similar sensitivity to the phar- maceuticals ketoprofen, ibuprofen 
and naproxen (Fig. 6c). 
The results showed that diclofenac was the only pharmaceutical that might be 
expected to pose an ecotoxicological risk to ﬁsh. Furthermore, HQs higher than 
one were observed in seawaters classiﬁed as excellent bathing water 
(Lavadores beach (Vila Nova de Gaia)) (European Comission, 2006). These 
ﬁndings are evidence that legislation has to be updated in order to consider 
other parameters beyond microbiological ones, since emerging pollutants as 
pharmaceuticals have been detected in seawaters, sometimes at levels that can 
pose an ecotoxicological risk to non-target organisms. Additionally, diclofenac 
was recently included in a watch list to gather monitoring data of its occurrence in 
surface waters, including coastal and marine waters, as well as to assess its 
environmen- tal impact (European Comission, 2013). Contrarily to what happens 
in Portuguese seawaters, a HQ of 0.004 for diclofenac was reported in north- ern 
Taiwan seawaters (Fang et al., 2012). 
The evaluation of environmental risk assessment followed herein only 
focused on the ecotoxicity that individual pharmaceuticals might pose to 
aquatic organisms. Nevertheless, pharmaceuticals occur in the environment as 
complex mixtures of different therapeutic groups, their metabolites and 
transformation products that may have synergis- tic or additive effects and, 
consequently, showing higher toxicities than individual compounds. In fact, 
combinatory effects were observed for different NSAIDs when analyzed as a 
mixture, having more toxicity than individual pharmaceuticals (Cleuvers, 
2003, 2004), as well as when in the presence of pharmaceuticals of other 
therapeutic groups (DeLorenzo and Fleming, 2008; Quinn et al., 2009). 
 
 
4. Conclusions 
 
The presence of NSAIDs and analgesic pharmaceuticals and metabo- lites was 
for the ﬁrst time reported in Portuguese seawaters at concen- trations up to 
1227 ng L−1. The highest concentrations for most of the pharmaceuticals 
found in seawaters were reported in Porto coastal area, showing that more 
densely populated areas have a high impact of anthropogenic activities. 
Seawaters with different bathing water quality classiﬁcations (excellent, 
good and sufﬁcient) were studied and all the nine compounds were detected 
in at least one sample. Mul- 
tivariate statistical analysis showed to have a positive correlation be- tween 
bathing waters classiﬁed as sufﬁcient and a more pronounced impact of 
human activities. A temporal evaluation of their occurrence along bathing 
season showed that higher concentrations were reported in August and 
September months, which can be due to an increment of population in the study 
areas during the holidays. Environmental risk assessment posed by 
pharmaceuticals found in seawaters was also eval- uated, showing that only 
diclofenac had a HQ higher than one for ﬁsh and therefore may pose a risk for 
aquatic organisms. 
The obtained data suggests that legislation should be updated in order to 
consider other parameters beyond microbiological ones in the classiﬁcation of 
bathing water quality. In addition, more monitoring studies should be made in 
order to better understand the level of pollu- tion of marine environment and 
establish actions to prevent and reme- diate the introduction of emerging 
contaminants into seawaters. 
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